iHuman Inc. Unveils 2024 Financial Results and Future Outlook

iHuman Inc. Announces Fourth Quarter and Fiscal Year Financial Results
iHuman Inc. (NYSE: IH), a frontrunner in tech-powered intellectual development products, recently disclosed its unaudited financial results for the fourth quarter and the entire fiscal year 2024. The company continues to demonstrate resilience amid changing market conditions, ensuring its dedication to providing innovative solutions for childhood education.
Fourth Quarter 2024 Highlights
The company reported revenues of RMB232.7 million (approximately US$31.9 million), marking a decline from RMB250.4 million recorded during the prior year's fourth quarter. This dip was attributed mainly to a decrease in birth rates in the region and a shift towards more cautious consumer spending.
Gross Profit Analysis
In this quarter, gross profit stood at RMB156.4 million (US$21.4 million), compared to RMB178.2 million in the same period last year. The gross margin saw a slight contraction, settling at 67.2%, down from 71.2% due to efforts in diversifying and enhancing product offerings.
Operating and Net Income
Operating income for the fourth quarter was recorded at RMB14.9 million (US$2.0 million), a decrease from RMB21.9 million a year earlier. On a positive note, net income reached RMB26.5 million (US$3.6 million), although it declined from RMB33.3 million in the previous year. The monthly active user (MAU) count increased to 25.78 million, reflecting growth in engagement with iHuman's products.
Fiscal Year 2024 Overview
For the full fiscal year, iHuman recorded revenues of RMB922.2 million (US$126.3 million), down from RMB1,018.1 million in 2023. The company's gross profit hit RMB640.2 million (US$87.7 million), reflecting a significant adjustment from the previous fiscal year's RMB721.3 million.
Annual Operational Metrics
Operating income saw a substantial drop to RMB71.9 million (US$9.9 million) from RMB159.9 million the year prior. However, net income was reported at RMB98.6 million (US$13.5 million), also down from RMB180.9 million in 2023. Despite these reductions, the growth in average total MAUs to 26.47 million—an increase from 23.04 million—indicates a successful user acquisition strategy.
Innovation and Market Trends
Dr. Peng Dai, Director and Chief Executive Officer of iHuman, emphasized the company’s commitment to innovation, particularly through artificial intelligence. The establishment of their AI Lab in 2018 has led to the integration of AI-generated content into their educational tools. The advent of products like iHuman Smart Coder showcases their innovative approach, offering personalized learning experiences in coding through intuitive user interactions.
Continuing to Innovate
As iHuman navigates the landscape of education technology, its strategy focuses on merging AI capabilities with traditional learning methods to enhance user engagement. The company is proactively aligning its offerings with market trends, ensuring their products remain relevant and effective in a constantly evolving market.
Special Cash Dividend Announced
The Board of Directors has approved a special cash dividend of US$0.02 per ordinary share, reaffirming the company’s commitment to shareholder value. This continuous dividend payment highlights the strength and resilience of iHuman’s business model even in challenging economic conditions.
Animation Studio Developments
Furthermore, the company’s animation studio, Kunpeng, has made strides in commercializing their animation properties, notably the successful Rainbow Crew series, which has boosted their brand presence and user engagement. Launching merchandise and expanding into global platforms such as YouTube showcases iHuman's innovative marketing strategies as they look toward international growth.
Future Growth and Strategies
As iHuman sets its sights on 2025, continued improvements in product innovation and market adaptation remain essential. The integration of AI technologies alongside creative content development will guide their mission forward, ultimately enhancing user experiences globally. With persistent commitment to innovation, iHuman Inc. is poised to thrive and expand within the competitive landscape of childhood education technology.
Frequently Asked Questions
1. What were iHuman's revenues for the fourth quarter of 2024?
iHuman reported revenues of RMB232.7 million (US$31.9 million) for the fourth quarter of 2024.
2. How did iHuman's gross profit change in 2024?
In 2024, iHuman's gross profit was RMB640.2 million (US$87.7 million), down from RMB721.3 million the previous year.
3. What innovative products has iHuman developed recently?
iHuman recently developed the iHuman Smart Coder, providing personalized coding education through AI integration.
4. What dividend has iHuman announced?
The Board of Directors has approved a special cash dividend of US$0.02 per ordinary share.
5. What is the future outlook for iHuman Inc.?
iHuman aims to further strengthen its product innovation and market relevance through AI advancements while focusing on user engagement and international expansion.
About The Author
Contact Caleb Price privately here. Or send an email with ATTN: Caleb Price as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.